Intriguingly, recent studies have revealed novel functions of DNA-PKcs in cancer, such as cell cycle progression, tumor metastasis and resistance to therapy, metabolic regulation, and tumor immunity [7,17,18,19,20,21], which transforms the paradigm of DNA-PKcs and expands the utility of DNA-PKcs inhibitors in cancer treatment. The gene discussed is PRKDC; the disease is neoplasm.